DISTRIBUTION OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII STRAINTS AT THE UNIVERSITY MEDICAL CENTER HO CHI MINH CITY

Thị Hồng Điệp Đường1,, Thị Phụng Cao1
1 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Background: Infections caused by Acinetobacter baumannii in the hospital cause many serious consequences when the rate of its antibiotic resistance is increasing, especially carbapenem. Objective: to determine the rate of antibiotic resistance, sample types, interventional procedures, the prevalence of A. baumanii infection in clinical departments in the hospital. Methods: The design of a cross-sectional study investigated 76 isolated cases of A. baumannii infection, which were performed at the Hospital of Medical University of Medicine and Pharmacy in Ho Chi Minh City from May 2020 to November 2020. Results: The rate of resistance to imipenem and meropenem was 93.4%. A. baumannii infection departments: ICU (54.0%). Types of infections: Lower respiratory tract infections (71.1%), blood infections (36.8%), skin and soft tissue infections (23.2%). Major sample types: Sputum, bronchial fluid (64.5%). Type of interventional procedure: respiratory intervention (75.0%), intravenous intervention (36.5%). Conclusion: The carbapenem resistance was 93.4% (imipenem and meropenem) mostly in patients with lower respiratory tract infections.

Article Details

References

1. Hoang Quoc C (2019), "Carbapenemase Genes and Multidrug Resistance of Acinetobacter Baumannii: A Cross Sectional Study of Patients with Pneumonia in Southern Vietnam", Antibiotics. 8(3).
2. Tarafdar F, Jafari B Azimi T (2020), "Evaluating the antimicrobial resistance patterns and molecular frequency of bla (oxa-48) and bla (GES-2) genes in Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from burn wound infection in Tehran, Iran", New microbes and new infections. 37, pp. 100686-100686.
3. Al-Mathkhury H. (2013), "Imipenem-Resistant Acinetobacter baumannii isolated from patients and hospitals environment in Baghdad", Iraqi Journal of Science. 54, pp. 803-812.
4. Thirapanmethee K. (2020), "Prevalence of OXA-Type β-Lactamase Genes among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates in Thailand", Antibiotics. 9(12).
5. Hsu LY (2017), "Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia", Clin Microbiol Rev. 30(1), pp. 1-22.
6. Tuan Anh N (2017), "Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam", J Med Microbiol. 66(1), pp. 46-53.
7. Trần Văn Ngọc, Phạm Thị Ngọc Thảo Trần Thị Thanh Nga (2016), "Khảo sát đặc điểm kháng thuốc của Pseudomonas Aeruginosa & Acinetobacter baumannii gây viêm phổi bệnh viện", Thời sự y học 03/2017. 20(1), tr. 85-90.
8. Nguyễn Ánh Tuyết (2019), "Khảo sát tỉ lệ phân lập và đề kháng kháng sinh của Acinetobacter baumannii tại Bệnh viện Nhân dân Gia Định năm 2018-2018", Tạp chí Y học TPHCM. 23(6), tr. 138-143.